{"id":27254,"date":"2021-02-04T14:59:28","date_gmt":"2021-02-04T20:59:28","guid":{"rendered":"https:\/\/goldenti.com\/site\/?p=27254"},"modified":"2021-02-04T14:59:30","modified_gmt":"2021-02-04T20:59:30","slug":"el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech","status":"publish","type":"post","link":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/","title":{"rendered":"El c\u00e1ncer ser\u00e1 tratado en &#8216;tres a cinco a\u00f1os&#8217; con tecnolog\u00eda ARNm, seg\u00fan BioNTech"},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"608\" height=\"337\" src=\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png\" alt=\"\" class=\"wp-image-27255\" srcset=\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png 608w, https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16-300x166.png 300w\" sizes=\"(max-width: 608px) 100vw, 608px\" \/><\/figure><\/div>\n\n\n\n<p>El c\u00e1ncer podr\u00e1 ser tratado con la tecnolog\u00eda del ARN mensajero, base de vacunas contra el&nbsp;covid-19, y los cient\u00edficos prev\u00e9n que en \u201ctres a cinco a\u00f1os\u201d haya f\u00e1rmacos disponibles de este tipo para tratar la enfermedad, afirm\u00f3 este jueves 4 de febrero de 2020 el vicepresidente de Bioqu\u00edmica en BioNTech, Andreas Kuhn. \u201cTenemos ya f\u00e1rmacos en desarrollo cl\u00ednico y se prev\u00e9 que en los pr\u00f3ximos tres a cinco a\u00f1os, tras ser aprobados, puedan ponerse a disposici\u00f3n de los pacientes oncol\u00f3gicos\u201d, dijo el investigador, quien avis\u00f3 ante el comit\u00e9 especial del Parlamento Europeo para combatir el c\u00e1ncer que dicha declaraci\u00f3n hay que tomarla \u201ccon cautela\u201d. Kuhn, que particip\u00f3 este jueves en una audiencia celebrada en el Parlamento Europeo (PE) por el D\u00eda Mundial contra el C\u00e1ncer, hizo hincapi\u00e9 en que para demostrar si las vacunas funcionan contra esta enfermedad \u201chay que trabajar con pacientes oncol\u00f3gicos\u201d. El cient\u00edfico de la compa\u00f1\u00eda alemana explic\u00f3 que el ARN terap\u00e9utico \u201cno es nuevo\u201d y destac\u00f3 su \u201cgran potencial\u201d para desarrollar nuevos tipos de medicamentos que combatan enfermedades infecciosas y tambi\u00e9n como tratamiento contra el c\u00e1ncer. \u201cEstos tratamientos con ARN mensajero funcionar\u00e1n solo en caso de detecci\u00f3n precoz de la enfermedad\u201d, puntualiz\u00f3 Kuhn, a lo que a\u00f1adi\u00f3 que \u201cen caso de detecci\u00f3n tard\u00eda del c\u00e1ncer ya no servir\u00e1n\u201d. Seg\u00fan sostuvo el experto, en las etapas iniciales ser\u00e1 posible inducir respuestas inmunol\u00f3gicas que ataquen a las c\u00e9lulas cancer\u00edgenas. Tambi\u00e9n insisti\u00f3 en que el apoyo a la innovaci\u00f3n para acelerar el desarrollo de nuevos hallazgos es fundamental para que las nuevas tecnolog\u00edas salgan adelante \u201cy no solo el ARN mensajero, que es muy prometedora, sino otro tipo de enfoques que est\u00e1n a\u00fan en ensayos cl\u00ednicos\u201d, aclar\u00f3. Kuhn se\u00f1al\u00f3 adem\u00e1s que si la vacuna contra el coronavirus ha sido posible desarrollarla en un periodo de tiempo tan breve, la ciencia deber\u00eda contar con \u201cnuevos mecanismos\u201d que aceleren el desarrollo de nuevos medicamentos porque, a\u00f1adi\u00f3, a largo plazo habr\u00e1 m\u00e1s muertos por c\u00e1ncer que por covid-19. Por su parte, el presidente de la comisi\u00f3n especial de la Euroc\u00e1mara de Lucha contra el C\u00e1ncer, Bartosz Arlukowicz, record\u00f3 c\u00f3mo la pandemia ha endurecido las condiciones de los pacientes de una enfermedad de la que fueron diagnosticadas a 2,7 millones de personas en Europa el a\u00f1o pasado. La Comisi\u00f3n Europea (CE) present\u00f3 ayer el Plan Europeo para Combatir el C\u00e1ncer, una de las prioridades de la legislaci\u00f3n de Ursula Von der Leyen, con el foco en las medidas de prevenci\u00f3n, ya que el 40% de los casos son prevenibles. El Plan estar\u00e1 dotado con una financiaci\u00f3n de 4 000 millones de euros para luchar contra una enfermedad que acab\u00f3 en 2020 con la vida de 1,3 millones de personas en la UE y, entre ellas, m\u00e1s de 2 000 j\u00f3venes. Entre los objetivos del club comunitario destaca que menos del 5% de la poblaci\u00f3n consuma tabaco de aqu\u00ed a 2040 y que la ingesta nociva de alcohol se reduzca al 10% en 2025<\/p>\n\n\n\n<p><strong>Fuente:<\/strong> <span class=\"has-inline-color has-vivid-cyan-blue-color\">www.elcomercio.com<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El c\u00e1ncer podr\u00e1 ser tratado con la tecnolog\u00eda del ARN mensajero, base de vacunas contra el&nbsp;covid-19, [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":27255,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-27254","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticas"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>El c\u00e1ncer ser\u00e1 tratado en &#039;tres a cinco a\u00f1os&#039; con tecnolog\u00eda ARNm, seg\u00fan BioNTech -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El c\u00e1ncer ser\u00e1 tratado en &#039;tres a cinco a\u00f1os&#039; con tecnolog\u00eda ARNm, seg\u00fan BioNTech -\" \/>\n<meta property=\"og:description\" content=\"El c\u00e1ncer podr\u00e1 ser tratado con la tecnolog\u00eda del ARN mensajero, base de vacunas contra el&nbsp;covid-19, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-04T20:59:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-02-04T20:59:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png\" \/>\n\t<meta property=\"og:image:width\" content=\"608\" \/>\n\t<meta property=\"og:image:height\" content=\"337\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"El c\u00e1ncer ser\u00e1 tratado en &#8216;tres a cinco a\u00f1os&#8217; con tecnolog\u00eda ARNm, seg\u00fan BioNTech\",\"datePublished\":\"2021-02-04T20:59:28+00:00\",\"dateModified\":\"2021-02-04T20:59:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/\"},\"wordCount\":559,\"image\":{\"@id\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png\",\"articleSection\":[\"Noticas\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/\",\"url\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/\",\"name\":\"El c\u00e1ncer ser\u00e1 tratado en 'tres a cinco a\u00f1os' con tecnolog\u00eda ARNm, seg\u00fan BioNTech -\",\"isPartOf\":{\"@id\":\"https:\/\/goldenti.com\/site\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png\",\"datePublished\":\"2021-02-04T20:59:28+00:00\",\"dateModified\":\"2021-02-04T20:59:30+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#primaryimage\",\"url\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png\",\"contentUrl\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png\",\"width\":608,\"height\":337},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/goldenti.com\/site\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El c\u00e1ncer ser\u00e1 tratado en &#8216;tres a cinco a\u00f1os&#8217; con tecnolog\u00eda ARNm, seg\u00fan BioNTech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/goldenti.com\/site\/#website\",\"url\":\"https:\/\/goldenti.com\/site\/\",\"name\":\"\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/goldenti.com\/site\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/goldenti.com\/site\/author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El c\u00e1ncer ser\u00e1 tratado en 'tres a cinco a\u00f1os' con tecnolog\u00eda ARNm, seg\u00fan BioNTech -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/","og_locale":"es_ES","og_type":"article","og_title":"El c\u00e1ncer ser\u00e1 tratado en 'tres a cinco a\u00f1os' con tecnolog\u00eda ARNm, seg\u00fan BioNTech -","og_description":"El c\u00e1ncer podr\u00e1 ser tratado con la tecnolog\u00eda del ARN mensajero, base de vacunas contra el&nbsp;covid-19, [&hellip;]","og_url":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/","article_published_time":"2021-02-04T20:59:28+00:00","article_modified_time":"2021-02-04T20:59:30+00:00","og_image":[{"width":608,"height":337,"url":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#article","isPartOf":{"@id":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/"},"author":{"name":"","@id":""},"headline":"El c\u00e1ncer ser\u00e1 tratado en &#8216;tres a cinco a\u00f1os&#8217; con tecnolog\u00eda ARNm, seg\u00fan BioNTech","datePublished":"2021-02-04T20:59:28+00:00","dateModified":"2021-02-04T20:59:30+00:00","mainEntityOfPage":{"@id":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/"},"wordCount":559,"image":{"@id":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#primaryimage"},"thumbnailUrl":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png","articleSection":["Noticas"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/","url":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/","name":"El c\u00e1ncer ser\u00e1 tratado en 'tres a cinco a\u00f1os' con tecnolog\u00eda ARNm, seg\u00fan BioNTech -","isPartOf":{"@id":"https:\/\/goldenti.com\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#primaryimage"},"image":{"@id":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#primaryimage"},"thumbnailUrl":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png","datePublished":"2021-02-04T20:59:28+00:00","dateModified":"2021-02-04T20:59:30+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#primaryimage","url":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png","contentUrl":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2021\/02\/image-16.png","width":608,"height":337},{"@type":"BreadcrumbList","@id":"https:\/\/goldenti.com\/site\/el-cancer-sera-tratado-en-tres-a-cinco-anos-con-tecnologia-arnm-segun-biontech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/goldenti.com\/site\/"},{"@type":"ListItem","position":2,"name":"El c\u00e1ncer ser\u00e1 tratado en &#8216;tres a cinco a\u00f1os&#8217; con tecnolog\u00eda ARNm, seg\u00fan BioNTech"}]},{"@type":"WebSite","@id":"https:\/\/goldenti.com\/site\/#website","url":"https:\/\/goldenti.com\/site\/","name":"","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/goldenti.com\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"","url":"https:\/\/goldenti.com\/site\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts\/27254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/comments?post=27254"}],"version-history":[{"count":1,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts\/27254\/revisions"}],"predecessor-version":[{"id":27256,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts\/27254\/revisions\/27256"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/media\/27255"}],"wp:attachment":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/media?parent=27254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/categories?post=27254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/tags?post=27254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}